
## ANNUAL REPORT 2025 




Registered Company Number: 02294557 (England & Wales) Registered Charity Number: 800853 



## Contents 

## Page(s) 

|Contents|P|
|---|---|
|Welcome from the Chair of Trustees|2|
|Member statistics|3|
|Report of the Trustees|4|
|How we are supported|5|
|Results of the member survey|10|
|Our volunteers|11|
|Therapy services|12|
|Administrative details|14|
|Structure, governance and management|15|
|Kenny’s story|17|
|Financial overview|18|
|Statement of the Trustees’ responsibilities|20|
|Lynsey’s story|21|
|Statement as to disclosure of information to auditors|22|
|Independent auditors’ report|23|
|Consolidated statement of financial activities|27|
|Consolidated balance sheet|28|
|Consolidated cash flow statement|29|
|Notes to the consolidated cash flow statement|30|
|Notes to the financial statements|31|




**----- Start of picture text -----**<br>
Coming to the Centre changed my life, and<br>with everyone’s support I gradually got<br>some of my enthusiasm back. I started to<br>become the ‘old/new’ Sam.<br>Sam Purvis<br>Centre Member<br>**----- End of picture text -----**<br>


**1** 



## Welcome to the Chilterns Neuro Centre Report of the Trustees for the Year Ended 31 December 2025 

Looking back on 2025, I feel a deep sense of pride in everything the Chilterns Neuro Centre has achieved in what has been a truly remarkable year of growth and community impact, a year in which we celebrated our charity’s 40th anniversary which is wonderful testament to the impact we have made over the years. 

Our multi-condition programme has continued to go from strength to strength, with membership reaching 925 by the end of the year. Notably, over a third of our members are from the Parkinson’s and stroke community, highlighting both the growing demand for our services and the breadth of support we provide. 

The year has also been shaped by remarkable generosity and community engagement. Our PopUp Art Weekend and Run Prestwood events raised over £30,000 combined, while new additions such as Race the Light, delivered in partnership with Runaway Racing, brought fresh momentum. We were also delighted to reintroduce a fundraising ball after several years - an unforgettable evening that raised over £23,500. 

Together, these achievements reflect not only the generosity of our supporters, but also the strong and vibrant community that continues to grow around the Centre. 

The Centre continued to provide a comprehensive range of therapy services, from physiotherapy and hydrotherapy to counselling and occupational therapy, all delivered by our skilled team of professionals, not to mention our extensive range of wellbeing groups from art to Boccia and book groups which are all largely delivered by our skilled team of volunteers. **1** 

Feedback from our annual member survey underlines the value of this work, with 99% of respondents saying they would recommend the Centre to others living with neurological conditions. 

My sincere thanks go to our dedicated staff, Trustees and volunteers, whose collective efforts make our work possible. Our volunteers, in particular, are central to everything we do - giving their time, skills and energy to create a supportive and welcoming environment for all. Thanks to their continued commitment, we are able to deliver meaningful, life-enhancing support to our members and their families, both now and into the future. 

**Liz Lawrence-Blake Chair of Trustees** 

**2** 



## **Member Statistics 2025** 



**----- Start of picture text -----**<br>
600<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
500<br>400<br>During 2025, the<br>300 Centre grew from 840<br>members to 925.<br>200<br>100<br>0<br>MS Parkinson's Carer Stroke<br>**----- End of picture text -----**<br>


Members access our services from all across the region. 

720 members received direct support from the Centre during 2025. On average, 366 members were supported every month. 


**----- Start of picture text -----**<br>
6000<br>5000<br>Our wide range of<br>4000 services were accessed a<br>total of 17,564 times<br>3000<br>during 2025.<br>2000<br>1000<br>0<br>Exercise ClassesPhysioOxygen TherapyComplementary TherapyWellbeing GroupsOccupational TherapyClinical CounsellingNew Member AssessmentsSpeech/Language TherapyNutritionCarer Support<br>**----- End of picture text -----**<br>


**3** 



## Report of the Trustees: strategic report 

## **Finance** 

Following our successful transition to a multi-condition Centre in 2023, our primary goal for 2025 was to further consolidate this expansion while maintaining financial sustainability. Despite very challenging fundraising conditions which were prevalent across the whole charity sector, we delivered a positive net surplus of £533,572 which included a heavily restricted one-off endowment grant of £500,000 (see detailed note below). This has demonstrated the effectiveness of our multi-condition expansion strategy. 

Total income reached £1,753,738, representing a 23% increase from the previous year's £1,421,103. 

We have continued to see growth in our corporate partnerships, and in donations and legacies, which reflects the value of four decades of incredible impact we have created in our community. 

The financial results offer further confirmation of tight management controls and efficiency in our operations. This financial stability has enabled us to continue investing in staff training, development and wellbeing initiatives and enhance our service delivery across all neurological conditions we support. 

## **Strategic Objectives Achieved in 2025** 

- 1.Service Integration: Successfully developed four core pathways for our members ensuring they are adequately supported throughout the different stages of their journey. 

- 2.Community Engagement: Expanded our volunteer programme to over 90 regular volunteers. 

- 3.Fundraising Diversification: Achieved record performance in community events and corporate partnerships 

- 4.Digital Innovation: Enhanced our member communication systems and donation outlets 

- 5.Clinical Excellence: Maintained high satisfaction rates. 

## **Risk Management** 

The Board continues to work closely with our Health and Safety adviser to identify and manage the principal risks facing the charity. A risk register is maintained and reviewed by the trustees, covering financial, operational, reputational, and governance risks. Each risk is assessed for likelihood and potential impact and assigned appropriate mitigating controls. Key risks identified during the year included the sustainability of income, safeguarding the charity's funds and assets, and compliance with regulatory requirements, and the trustees are satisfied that suitable systems and internal controls are in place to manage these risks. The trustees will continue to monitor the risk environment and update the register as circumstances change, ensuring that risk management remains embedded in the charity's planning and decision-making. 

**4** 



## **Future Plans** 

Looking ahead to 2026-2027, we are developing a new strategic plan that will focus on sustainable growth, enhanced clinical outcomes measurement, and exploring opportunities to share our successful multi-condition model with other Centres in the neurological charity sector. 

## How we are supported 

## **Our Income** 

The charity undertakes a broad range of fundraising activities, including events and sponsorship, applications to grant-making trusts, corporate, individual and community donations. All activities are in line with the Code of Fundraising Practice set by the Fundraising Regulator, of which the Centre is a member. 


**----- Start of picture text -----**<br>
Membership subscriptions<br>Earned Income (£22,626 | 1%)<br>£48,002 | 3%) Gift Aid<br>(£36,650 | 2%) Investment income<br>Public Donations<br>(£18,042 | 1%)<br>£53,653 | 3%)<br>Corporate<br>(£64,832 | 4%)<br>Endowments<br>Integrated Care (£500,000 | 29%)<br>Board  (£66,996 | 4%)<br>Donations from<br>members  (£98,652 | 6%)<br>Major donors<br>(£104,900 | 6%)<br>Legacies<br>(£123,290 | 7%)<br>Trusts & Foundations<br>(£336,203 | 19%)<br>Oakwood Wellbeing<br>Ltd  (£124,992 | 7%)<br>Community & Events<br>(£154,900 | 9%)<br>**----- End of picture text -----**<br>


**5** 



## **Fundraising** 

## **Corporate Support** 

Our corporate support sustained the 50% growth found in 2024 and generated over £66,000 in 2025. We are lucky to have ongoing support from our corporate friends who provide regular monthly donations and a well established network of corporate associations which continues to grow each year. We also benefit from a number of corporate sponsors who kindly support many of our external events and we are grateful that many of them do this on an ongoing basis, showing their commitment to our work. 

Our strategic associations in 2025 included Ashridge Home Care, Steering Developments, Hollister Incorporated, Better Mobility and Laybrook. All of these have continued to flourish during the year, and Eximius Live-In Care joined us at the end of 2025. These companies provide both financial support and collaborative opportunities that directly benefit our members and we have enjoyed working with them on events such as our annual Live Well Roadshow and Mini Expo. 

## **Individual giving and member donations** 

We remain committed to trying to ensure that beyond the annual membership, all services continue to be offered free of charge. However, we are grateful that many members do make regular donations – along with our supporters – and this support remains absolutely crucial to our operations. Combined with membership fees, this support brings in over £121,278 to the Centre. 

Though our membership numbers increased in 2025, the value of membership donations decreased by 5%. This is reflective of the trends within the charity sector with people able to give less as we navigate the cost-of-living crisis. Our average gift size reduced slightly and the number of members donating stayed around the same despite an uplift in people being supported by the charity. 

* We do offer access to a hardship fund should this fee be an issue for anyone needing our services. 

## **Trusts** 

Grants income in 2025 totalled £336,203 made up of £283,203 for specific projects and £53,000 in unrestricted funding. Our thanks go to all the grant-makers whose support we can acknowledge publicly: 

   - Access Group Foundation 

   - Arnold Clark Community Fund Aston Clinton Charitable Foundation Ernest Hecht Charitable Foundation Fairhive Homes Ltd 

- Thriving Communities Fund Goodman Foundation 

   - King/Cullimore Charitable Trust Mulberry Trust through Heart of Bucks Mobbs Memorial Trust 

- National Lottery 

- Reaching Communities Fund PF Charitable Trust Shanly Foundation 

   - The E M MacAndrew Trust The February Foundation The Hospital Saturday Fund The Spurrell Charitable Trust The Stockwell-Cliffe Charitable Trust Thomas Hickman’s Charity William Harding’s Charity 

**6** 



Funding was received for the following projects: 

- Physiotherapy Programme (£104,500) 

- Physiotherapy Equipment (£3,253) 

- Clinical Services (£150,000) Wellbeing Programme (£11,700) Counselling (£10,000) 

- Oxygen Therapy (£3,750) 



We are particularly grateful for the final instalments of our three-year grant from the National Lottery Community Fund’s Reaching Communities programme, to help fund our clinical services from 2023-2025, and to the Ernest Hecht Charitable Foundation for their incredible £500,000 endowment to help deliver our Physiotherapy services until 2033. 

The endowment from Ernest Hecht has been jointly invested with another endowment we received in 2024 from the Edward Gostling Foundation as one of their Legacy Partners. 

This is generating investment income for our charity that amounted to interest and dividend income of £13,601 and portfolio gains of £84,095 in 2025. 

## **Endowment Funds** 

**(** A note for our funders and supporters on the nature and availability of these funds.) 

During the 2024 and 2025 financial periods, the Centre has been honoured to receive two exceptional gifts: **£500,000 from the Ernest Hecht Charitable Foundation** and **£230,000 from The Edward Gostling Foundation** . Both gifts were made by way of Deed of Gift and were recognised in full as restricted income in our Statement of Financial Activities in the year of receipt, as accounting standards require. The funds have been placed in a dedicated restricted managed investment portfolio with Quilter Cheviot, a specialist charity investor service, where they are prudently invested pending release. 

Because these gifts are recognised in the year of receipt, they make our reserves appear substantially larger than the resources actually available to us. In reality, both funds are tightly restricted — in how they may be spent and, critically, in when they may be drawn upon. They cannot be applied freely to our day-to-day running costs. 

## **The Ernest Hecht Charitable Foundation Fund — £500,000** 

This gift, made under a Deed of Gift dated 28 February 2025, exists to safeguard the continuity of our physiotherapy programme. Under the terms of the Deed, for a period of at least eight years from 1 January 2026 the Centre must allocate **£65,000 each year, restricted solely to the provision of physiotherapy** . The balance must remain prudently invested, with all investment returns ring-fenced for the physiotherapy programme. 

**7** 



## **The Edward Gostling Fund — £230,000** 

This endowment, established by a Deed of Gift dated 12 March 2024, is held and reported in our accounts as “The Edward Gostling Fund”. For five years from that date, the fund may only be used to meet operating costs, and then only as a safety net: drawdowns in any accounting year are limited to the amount needed to prevent our reserves falling below three months’ operating costs, in line with the Charity Commission’s reserves guidance (CC19). In effect, the fund **protects the Centre’s resilience rather than funding routine expenditure** . From 12 March 2029 any income and remaining capital may be applied to any purpose within our charitable objects. 

## **What this means for our funding needs** 

These two farsighted gifts give the Centre valuable long-term security: one underpins a single core service in fixed annual amounts over many years, and the other acts as a reserve of last resort. Neither, however, funds the annual cost of delivering our full range of therapies and support to people living with multiple sclerosis, Parkinson’s and the effects of stroke. The Centre must still raise the substantial majority of its running costs each year, and the continued generosity of trusts, foundations and major donors remains essential to sustaining our services. 

## **Community and events** 

Community fundraising continues to thrive and contributed £164,000 to the Centre in 2025. This is a 6% increase on 2024 and a 19% increase over two years. We had another record year with our annual Pop-Up Art Weekend raising over £21,000 and added a Ruby Ball at Pendley Manor in Tring to our 40th Anniversary celebrations which raised over £23,500. 

We were proud to introduce some new events too including a Bingo night, a second golf day at Western Turville Golf Club and Race the Light; a running event which included a 1km accessible race which many of our members took part in. 




We were grateful also for donations from Rotary Clubs, the local Freemasons and many generous clubs and societies. We also benefited significantly from income raised from a number of wonderful individual fundraisers; from marathon runners, to candle makers and offerings from one of our very own members taking over our café and cooking up a storm to raise money for the Centre. 

## **Legacy and in-memory** 

Legacy gifts totalled £122,000 in 2025. We were fortunate to receive three legacies, including one six-figure gift, for which we are deeply grateful. This significant gift meant that this was a huge area of increase since 2024. 

We continue to promote legacy giving through our communications and through Make A Will month each year, as these gifts provide crucial long-term sustainability for the Centre. We are humbled to have a number of legacy pledgers who are committed to supporting the future of the charity. 

## **Oakwood Wellbeing Ltd** 

Oakwood Wellbeing Limited (OWL), our wholly-owned subsidiary, continued its strong performance in 2025. The company generated £124,992 in outside usage income, with net profits of £74,000 being gift-aided to the charity. Use of the hydrotherapy pool remained consistent with swim schools providing £70,679 of income. The main growth areas were private oxygen with a £7,115 increase and room hire with growth of £9,373. 

Combined with service charges, OWL contributed £106,400 to the Centre's operations, demonstrating the continued value of maximising the use of our specialist facilities and services offered to the local community. 




## **Annual Member Survey 2025** 


**In total there were 297 responses, 32% of the Centre’s** 95% of members stated they would recommend the Centre **membership. The number of responses was an increase** to someone with a neurological condition or their carer. **from last year and percentage of members was the same.** 

**99%** 

**99% of those who responded said they would recommend the Centre to someone with a neurological condition or their carer.** 


**87% of members agreed 87% the Centre helped manage their symptoms at least most of the time.** 

**75% of members agreed the 75% Centre helped them stay active in the community at least most of the time. 82% of members agreed the 82% Centre helped maintain their independence at least most of the time.** 

**89% of members agreed the Centre helped 89% improve their physical health at least most of the time.** 

**87% of members agreed the Centre helped 87% improve their mental health at least most of the time.** 

**75%** 

**75% of members agreed the Centre helped increase their social contact and reduce feelings of loneliness at least most of the time.** 

“It gives me a purpose to get up in the mornings, to come and enjoy a class or activity and meet with friends I’ve made there.” 

“It’s my lifeline.” 

“It offers more than just therapy, it’s a place of hope and understanding.” 

“It helps me to rediscover confidence, purpose and the joy of everyday life.” 

**10** 



## Our volunteers 

Volunteers are the lifeblood of so many charities, bringing not only time and skills but also compassion, energy and a deep sense of community. 

Nowhere is this more evident than at the Centre, where volunteers play a vital role in ensuring that our members receive the support, care and connection they need. 

“Our volunteers are at the very heart of everything we do. Their dedication, generosity and belief in our mission make it possible for the Chilterns Neuro Centre to deliver such a wide range of vital services. Quite simply, we could not operate without them—they are an integral part of our community and our success.” 

Richard Parkin, CEO 

Their contribution goes far beyond simply helping out. They are fundamental to the Centre’s ability to function, grow and deliver meaningful impact every single day. 

From the moment someone walks through the doors, volunteers help create a warm and welcoming environment. They staff reception, offering a friendly face and a reassuring presence, and keep the café running - a social hub where members can relax, connect and feel part of a community. 

Volunteers also support a wide range of wellbeing groups, helping to facilitate activities that improve both physical and mental health. The oxygen service, which provides essential therapy to many members, is sustained by dedicated volunteers who ensure it runs smoothly and safely. 

Meanwhile, others contribute their professional skills in areas such as finance, fundraising and communications - bringing expertise that strengthens our charity’s foundations and helps extend our reach. This range of support allows us maximise our resources and focus on what matters most - empowering our members to live life to the full. 

Many thanks to all our lovely volunteers for your wonderful loyalty to our charity and those who we support. 

**11** 



## Therapy services 

The Centre has continued to provide a comprehensive range of clinical services to support members’ physical and mental wellbeing. We follow NICE guidelines and our philosophy centres on empowering members to effectively self-manage their conditions while providing expert professional support. 

## **New Care Pathways** 

During the last year, we introduced a new triaging system to help us respond effectively to increasing demand while continuing to provide equitable, person-centred support. 

Members are now assigned to one of four Care Pathways following an initial assessment or review: 

- Advanced 

- Rehabilitation 

- Supported Self-Management 

- Carers 

The Advanced and Rehabilitation pathways prioritise access to one-to-one treatments including physiotherapy, hydrotherapy, reformer Pilates, occupational therapy and counselling. The Supported Self-Management and Carers pathways focus on exercise classes, wellbeing activities, peer support opportunities and symptom-management workshops. 

These pathways are designed to remain flexible, allowing individuals to move between them as their needs change over time. 




We have also strengthened support for carers who may be at risk of breakdown, offering urgent signposting to social care and mental health services where appropriate. Alongside this, we launched a series of new self-management courses covering nutrition, constipation and breath support, complementing our existing falls prevention and fatigue management programmes. 

## **Celebrating 40 Years of Support** 

In 2025, we marked the charity’s 40th anniversary, providing an opportunity to reflect on four decades of transforming the lives of local people affected by long-term neurological conditions. 

## **Responding to Growing Demand** 

“The facilities we enjoy today seem a world away from how they were in the past and, although we are very fortunate to have them, what really matters – the commitment, care and compassion – are exactly the same as they always were. Since my very first visit in 1992, the Centre has been a godsend to me and I am so thankful that I was pointed in the right direction all those years ago. You’re brilliant and we are so very lucky to have you!” 

Kay Lewis, centre member for 33 years 

Over the past 12 months, our clinical team have shown remarkable adaptability and resourcefulness in developing the new care pathways and self-management programmes described above. These initiatives are helping us continue to provide high-quality, equitable support to the growing number of people seeking our services. 

By the end of December, membership had grown to 925 people, compared with 563 just five years earlier. This growth has been achieved against a backdrop of ongoing COVID recovery and an extremely challenging fundraising environment, while maintaining the exceptionally high levels of positive feedback reflected in our annual service users’ survey. 

We are proud of the positive impact we continue to make within our community and remain committed to responding to increasing demand for specialist neurological support. 




## Administrative details 

## **Company details** 

Registered company number 02294557 (England and Wales) Registered charity number 800853 Registered office and principal address Chilterns Neuro Centre Oakwood Close, Wendover, Aylesbury, Buckinghamshire. HP22 5LX 

## **Trustees** 

Liz Lawrence-Blake (Chair) Karen Cross (appt Vice Chair March 2025) Darayus Motivala Simon Turner John Bedford Nicola Ewen (appt December 2025) Ian Summerfield (resigned February 2025) Henry Snow (Treasurer) (resigned February 2025) Robert Carter (resigned February 2025) Alison Heywood (resigned February 2025) 

## **Company Secretary** 

Liz Lawrence-Blake LLB (Hons) barrister-atlaw 

## **Chief Executive** 

Richard Parkin 

## **Leadership Team** 

Stella Kubale - Head of Fundraising (appt Deputy CEO October 2025) Lou Grace - Co-Therapy Service Lead Annette Cockroft - Co-Therapy Service Lead Andrew Scott - Communications Manager Dhiren Patel - Facilities Manager Jo Kendall - Oakwood and Clinical Administration Manager Jody Barber - Head of Integrated Clinical Services (made redundant June 2025) Eileen Inman - Finance Manager (made redundant November 2025) 

## **Telephone numbers** 

01296 696133 (Reception) 01296 823040 (Fundraising) 01296 823047 (Finance office) Website / Email www.chilternsneurocentre.org info@chilternsneurocentre.org 

## **Social media** 

Facebook: www.facebook.com/ ChilternsNeuro LinkedIn: ChilternsNeuro Instagram: @ChilternsNeuro 

## **Auditors** 

Dux Advisory Limited Kennel Club House Gatehouse Way Aylesbury Buckinghamshire HP19 8DB 

## **Bankers** 

National Westminster Bank Plc 22 Market Square Aylesbury Bucks HP20 1PR 

Lloyds Bank Plc 79 High Street Chesham Buckinghamshire HP5 1DE 

Santander 1st Floor Operations Block Bridle Road Bootle Merseyside L30 4GB 

## **Patrons** 

Trishna Bharadia BA (Hons) 

The Earl of Buckinghamshire Lord Carlile of Berriew KC Prof Gavin Giovannoni MBBCh PhD FCP FRCP FRCPath Derek K Townsend DL 

**14** 



**O** 

## Structure, governance and management 

## **Governing document** 

Chilterns Neuro Centre Ltd is registered with the Charity Commission for England and Wales and was incorporated as a company limited by guarantee on 9 September 1988. The charity is governed by its Articles of Association as amended at the Annual General Meeting held on 26 July 2018. 

## **Organisational structure** 

The Board of Trustees is responsible for overall management and governance, meeting monthly to set strategic direction, agree on budgets, and monitor performance. Day-to-day management is delegated to Chief Executive Richard Parkin, supported by the Leadership Team. 

## **Governance** 

The CEO and Chair meet regularly, with the Leadership Team providing monthly written reports to Trustees. Risk management, Human Resources, Health and Safety, and feedback from subcommittees form part of trustee meeting agenda. 

## **Five Permanent Committees:** 

- Income Generation and Finance Committee 

- Clinical Governance Committee 

- Health and Safety amd Facilities Committee Human Resources Committee 

- Oxygen Services Committee 


**----- Start of picture text -----**<br>
It helps me rediscover<br>confidence, purpose and<br>the joy of everyday life.<br>- Centre Member<br>**----- End of picture text -----**<br>


**15** 



**O** 

## **Recruitment and appointment of new Trustees** 

The Board works to maintain an appropriate balance of skills, knowledge, and experience. All Trustees are elected by membership, with one-third retiring by rotation at the AGM. New Trustees receive induction, including governance information and role descriptions. The Board ensures balance between Trustees with direct experience of neurological conditions and those without, ensuring beneficiary interests are represented while maintaining objective decision-making. 

## **Staff pay** 

Clinical staff pay is benchmarked to NHS Agenda for Change scales, while non-therapy staff salaries are benchmarked against similar positions in comparable charities. 

## **Risk management** 

The Board, CEO, and Leadership Team continuously review and monitor organisational risks, with specialist Health and Safety advice provided by our volunteer adviser. 

## **Public benefit** 

The Trustees have complied with their duty to have regard to the guidance on public benefit published by the Charity Commission in exercising their duties or powers. 

The activities of the charity are focused on providing significant support for those affected by MS, Parkinson’s and strokes through treatment and therapy, informal advice and peer support. 

## **Performance** 

The charity’s performance is monitored monthly using a range of activity reports and indicators. These inform the Board of Trustees and governance committees and enable the leadership team to measure performance against strategic objectives and inform future planning. 

## **Workplace pension** 

All eligible staff are enrolled in a workplace pension scheme and the charity made contributions in line with the statutory requirements. 

## **Professional development and training** 

All employed therapy staff are supported by professional training as appropriate and appraisals. 

Other staff are also supported if possible, to ensure their training needs are met and they develop additional skills within their roles. Training programmes for clinicians around the expansion to other conditions is ongoing. 

**16** 



## Kenny’s story 

Kenny Martin could be described as someone who embraced life as an adventure, experiencing anything and everything it had to offer him. He was very active, working long hours as a chef and enjoying exercise and a good social life after work. 

Living such a full life meant his MS diagnosis at the age of only 38 hit hard and changed his life dramatically. 

“I started noticing strange symptoms, such as pins and needles in my feet and hands and ‘brain fog’ and my memory became poorer. I relied on my memory in my job and, unfortunately, since the diagnosis, I’ve had to give up my job as my eyesight has also been impacted.” 

“I have difficulty focusing on things and, along with issues with coordination in my hands and legs, this prevents me from writing anything down.” 

“The Centre provides so much support and advice, it means I get what I need tailored to my specific symptoms. I have been able to receive treatments in physio, acupuncture and oxygen, and the staff have assisted me with referrals to other external services, such as orthotic and bladder clinics.” 

“Physio has helped to strengthen my legs, which I notice on the recumbent exercise bike. I am able to sustain longer periods of riding before fatigue sets in. Acupuncture and oxygen therapy have helped relieve bladder symptoms and I’m now sleeping through the night without needing to get up to go to the toilet.” 

“One of the most helpful things for me is that Centre staff have helped me to find coping strategies in how I deal with my MS. They provide outstanding advice and excellent feedback to help me adjust my life to benefit me better.” 

“On top of that, the Centre has also given me things to focus on, including fundraising challenges, which has provided a new purpose to my life.” 

“Interacting with people who understand what you’re going through has been incredibly helpful and given me insight into how it affects different people in different ways. Meeting others who have MS and hearing their stories and how they cope has given me more hope for the future.” Kenny has a different perspective on life now and his hopes for the future are mainly centred around what can be done to improve life for people with MS. 

“I hope more people make use of the Centre and its valuable resources. I would strongly recommend people get involved. Having MS can be a very lonely place but, by engaging with the Centre, you’ll realise you’re not alone. The Centre has changed my life. Its network of people, carers and support gives me purpose.” 


**17** 



**O** 

## **Financial overview** 

The main points of the results for 2025 are: 

Income for the year was largely consistent with the levels set in 2024 and consolidated the growth levels experienced in 2023 and 2024 posting a £1.75 million total, inclusive of a £500k endowment. 

This demonstrates the success of our diversified fundraising strategy and the continued support of our community as we establish ourselves as a multi-condition Centre. 

||**2023**|**2024**|**2025**|
|---|---|---|---|
||Multi-<br>Condition<br>Launch|Established<br>Expansion|Consolidation|
|**Total Income Reported**|**£1,045k**|**£1,421k**|**£1,754k**|
|||||
||**+7%**|**+36%**|**+23%**|



The Oakwood Wellbeing Limited trading subsidiary continued strong performance, benefiting from increased facility rentals and expanded service offerings to external organisations. 




## **Expenditure** 

Total expenditure increased to £1,308k in 2025 from £1,277k in 2024, a below inflation increase of 2.4%, representing careful cost management while maintaining all core services. 

## **Cash flow** 

In very difficult sector circumstances, we managed cash resources carefully and, despite a negative cash flow in the year, our cash reserves were £379k at year end, providing operational cover and positioning us within our 3-6 months reserves policy. 

## **Resource management** 

Our financial strategy continues to focus on sustainable service delivery and fundraising diversification. We successfully increased clinical capacity while maintaining our commitment to free services for all members. 

## **Performance indicators** 

The proportion of expenditure on the provision of treatments has fallen in the year. Although expenditure in this area has increased, the larger increase in the fundraising division reflects the continuing investment in this area. 

## **Fundraising multiple** 


**----- Start of picture text -----**<br>
2025 with 2025 2024<br>Endowment<br>£ £ £<br>Income raised through fundraising 1,433,756 933,756 917,039<br>Fundraising income classified with trading activities (sales) 68,048 68,048 48,483<br>Total - Excluding Oakwood Wellbeing income and membership fees 1,501,804 1,001,804 965,522<br>Expenditure on raising funds - including Oakwood direct costs 323,346 323,346 292,353<br>Less cost of goods sold 13,569 13,569 12,529<br>Less Oakwood direct costs 18,509 18,509 17,114<br>Pure fundraising costs 291,268 291,268 262,710<br>Fundraising multiple of income to cost 5.2 3.4 3.7<br>**----- End of picture text -----**<br>


2024 2025 **77p        of every £1 75p        of every £1 on care and support on care and support** 

## **Reserves** 

The Group's total reserves at 31 December 2025 were £3,338k, of which £104k were restricted, £775k were in endowments, leaving £2,459k of unrestricted general reserves, of which £2,313k was in buildings and equipment. 

**19** 



## Statement of the Trustees’ responsibilities 

The Trustees (who are also directors of the Chilterns Neuro Centre for the purposes of company law) are responsible for preparing the Trustees' Annual Report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to: 

- Select suitable accounting policies and then apply them consistently; Observe the methods and principles in the Charities SORP 2019 (FRS 102); Make judgments and estimates that are reasonable and prudent; 

- State whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation. 

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. 




## Lynsey's story 

Lynsey was diagnosed with MS in 1982 and, as she remembers it, available treatments were few and far between. The only viable option for any sort of treatment locally was at Wycombe Hospital, where they only offered physiotherapy. 

While reading the local paper one day, Lynsey was excited to learn that a brand new MS Centre, dedicated to providing treatments and therapies exclusively for people with MS, was due to open. The year was 1985. 

The new Centre would be located in the grounds of The Paddocks Hospital in Princes Risborough – close enough for an easy commute for Lynsey. Having had MS for three years, Lynsey was keen to try anything that might help improve her symptoms and prevent relapses. 

Lynsey recalls the Centre’s small beginnings: “My early memories were that the Centre consisted of a very small portacabin containing the oxygen chamber and a small group doing an exercise class, plus there was a tiny kitchen area!” Lynsey decided to take full advantage of what was on offer and went every single day for four weeks, starting with oxygen therapy, embracing something that would prove to be a huge benefit to her long-term. Lynsey would continue to use hyperbaric oxygen at the Centre, wanting to make the most of the benefits she experienced from the treatment from the very start. 

In 1990, the Centre relocated to a slightly larger, but just as modest, portacabin in Halton. Lynsey continued her oxygen treatment and added exercise classes into the mix. In 2012, the Centre moved into the purpose-built facility in its current location on the Princess Mary Gate Estate, Wendover. 

It continued to expand, extending its offering to people with Parkinson’s and stroke survivors in 2023 and growing to provide hydrotherapy, occupational and complementary therapies (including acupuncture and Yoga) and Pilates, massage, speech therapy, an MS information service and a carers’ support group. 

Lynsey has welcomed the progress she’s seen over the last four decades but the opening of the new building at Wendover was the most exciting change. “The new building was so much bigger and better and made such a difference – more treatments available, more staff. I had reflexology, foot massage and acupuncture, as well as exercise classes and one-to-one physiotherapy when I needed it. The most effective for me are currently the exercise classes and physio.” 


“The Centre has evolved in leaps and bounds over the years. There have been new buildings, new treatments and new staff, always improving and always doing the very best for members to lead as full a life as possible.” 

**21** 



## Statement as to disclosure of information to auditors 

Insofar as the Trustees are aware: 

- There is no relevant audit information of which the charitable company's auditor is unaware; and 

- The Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information. 

## **Auditors** 

Dux Advisory Ltd will be proposed for reappointment at the forthcoming Annual General Meeting. 

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act relating to small companies. 

Approved by order of the board of trustees on 4 August 2026 



**Liz Lawrence-Blake Chair of Trustees** 




## Independent auditor’s report to the members and Trustees of Chilterns Neuro Centre Ltd. 

## **Opinion** 

We have audited the financial statements of Chilterns Neuro Centre Ltd. (the ‘parent charitable company’) and its subsidiaries (the ‘group’) for the year ended 31 December 2025 in this report, which comprises a consolidated statement of financial activities, a consolidated balance sheet and a consolidated cash flow statement, and notes to the financial statements, including a summary of significant accounting policies. 

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). 

In our opinion the financial statements: 

- Give a true and fair view of the state of the group’s and parent charitable company’s affairs as at 31 December 2025, and of the group’s incoming resources and application of resources, including its income and expenditure, for the year then ended; 

- Have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and have been prepared in accordance with the requirements of the Companies Act 2006 and the Charities Act 2011. 

## **Basis for Opinion** 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. 

We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

**23** 



## **Conclusions relating to going concern** 

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you, where: 

- The Trustees’ use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or 

- The Trustees have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the group’s or parent charitable company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue. 

## **Other information** 

The Trustees are responsible for the other information. The other information comprises the information included in the Trustees’ annual report, other than the financial statements and our auditor’s report thereon.Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard. 

## **Opinions on other matters prescribed by the Companies Act 2006** 

In our opinion, based on the work undertaken in the course of the audit: 

- The information given in the Trustees’ report (incorporating the directors’ report) for the financial year for which the financial statements are prepared is consistent with the financial statements; and 

- The Report of the Trustees has been prepared in accordance with applicable legal requirements. 

**24** 



## **Matters on which we are required to report by exception** 

In light of our knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors’ report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 and the Charities Act 2011 require us to report to you if, in our opinion: 

- Adequate and sufficient accounting records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us; or 

- The parent charitable company’s financial statements are not in agreement with the accounting records and returns; or certain disclosures of directors’ remuneration specified by law are not made; or 

- We have not received all the information and explanations we require for our audit; or The Trustees were not entitled to prepare the financial statements in accordance with the small companies’ regime and take advantage of the small companies’ exemptions in preparing the directors’ report and from the requirement to prepare a strategic report. 

## **Responsibilities of Trustees** 

As explained more fully in the Trustees’ responsibilities statement set out in this report, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

In preparing the financial statements, the Trustees are responsible for assessing the group’s and parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or the parent charitable company or to cease operations or have no realistic alternative but to do so. 

## **Auditor’s responsibilities for the audit of the financial statements** 

We have been appointed auditor under the Companies Act 2006 and section 151 of the Charities Act 2011 and report in accordance with those Acts. 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities.This description forms part of our auditor’s report. 

**25** 



## **Use of our report** 

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and to the charitable company’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company’s members and its Trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body and the charitable company’s Trustees as a body, for our audit work, for this report, or for the opinions we have formed. 

Mr S Brownsmith FCA Senior Statutory Auditor For and on behalf of Dux Advisory Ltd, Statutory Auditor Kennel Club House Gatehouse Way Aylesbury Buckinghamshire, HP19 8DB 

August 2026 

Dux Advisory is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006. 




## **CHILTERNS NEURO CENTRE LTD. CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING CONSOLIDATED INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2025** 

|Unrestricted<br>Funds<br>Notes<br>£<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>3<br>639,553<br>**Charitable activities**<br>Provision of treatments, care and support for<br>people with MS<br>6<br>66,996<br>Other trading activities<br>4<br>234,944<br>Investment income<br>5<br>4,441<br>**Total**<br>945,934<br>**EXPENDITURE ON**<br>Raising funds<br>7<br>323,346<br>**Charitable activities**<br>Provision of treatments, care and support for<br>people with MS, Parkinson's, Stroke<br>8<br>682,466<br>**Total**<br>1,005,812<br>**NET INCOME/(EXPENDITURE)**<br>(59,878)<br>Gains / (Losses) on Investments<br>3,992<br>Transfers between funds<br>23<br>65,684<br>**Net movement in funds**<br>9,798<br>**RECONCILIATION OF FUNDS**<br>**Total funds brought forward**<br>2,450,196<br>**TOTAL FUNDS CARRIED FORWARD**<br>23<br>2,459,994|Restricted<br>Funds<br>£<br>294,203<br>-<br>-<br>-<br>294,203<br>-<br>302,441<br>302,441<br>(8,238)<br>-<br>(242,684)<br>(250,922)<br>354,943<br>104,021|Endowment<br>Funds<br>£<br>500,000<br>-<br>-<br>13,601<br>513,601<br>-<br>-<br>-<br>513,601<br>84,095<br>177,000<br>774,696<br>-<br>774,696|31.12.2025<br>Total  funds<br>£<br>1,433,756<br>66,996<br>234,944<br>18,042<br>1,753,738<br>323,346<br>984,907<br>1,308,253<br>445,485<br>88,087<br>-<br>533,572<br>2,805,139<br>3,338,711|31.12.2024<br>Total  funds<br>£<br>1,147,039<br>66,996<br>197,837<br>9,231<br>1,421,103<br>292,353<br>984,939<br>1,277,292<br>143,811<br>0<br>0<br>143,811<br>2,661,327<br>2,805,139|
|---|---|---|---|---|



## **The notes on pages 30 to 45 form part of these financial statements.** The notes on pages 29 to 44 form part of these financial statements. 

The statement of financial activities includes all gains and losses recognised in the year. 

All income and expenditure has arisen from continuing activities. 

**27** 



**(REGISTERED NUMBER: 02294557)** 

## **CHILTERNS NEURO CENTRE LTD. CONSOLIDATED BALANCE SHEET AT 31 DECEMBER  2025** 

|Notes<br>**FIXED ASSETS**<br>Tangible assets<br>14<br>Investments<br>15<br>**CURRENT ASSETS**<br>Stocks<br>16<br>Debtors<br>17<br>Cash at bank<br>**CREDITORS**<br>Amounts falling due within one year<br>18<br>**NET CURRENT ASSETS**<br>**TOTAL ASSETS LESS CURRENT LIABILITIES**<br>**CREDITORS**<br>Amounts falling due after more than one<br>year<br>19<br>**NET ASSETS**<br>**FUNDS**<br>23<br>Unrestricted<br>Restricted<br>Endowment<br>**TOTAL FUNDS**|Group<br>31.12.2025<br>31.12.2024<br>£<br>£<br>2,313,294<br>2,372,677<br>784,852<br>0<br>3,098,146<br>2,372,677<br>6,231<br>2,144<br>45,297<br>102,991<br>379,375<br>497,254<br>430,903<br>602,389<br>(112,968)<br>(74,131)<br>317,935<br>528,258<br>3,416,081<br>2,900,935<br>(77,370)<br>(95,796)<br>3,338,711<br>2,805,139<br>2,459,994<br>2,450,196<br>104,021<br>354,943<br>774,696<br>-<br>3,338,711<br>2,805,139|Charity<br>31.12.2025<br>31.12.2024<br>£<br>£<br>2,313,294<br>2,372,677<br>784,952<br>100<br>3,098,246<br>2,372,777<br>6,231<br>2,144<br>63,047<br>126,405<br>352,972<br>454,201<br>422,250<br>582,750<br>(105,170)<br>(55,261)<br>317,080<br>527,489<br>3,415,326<br>2,900,266<br>(77,370)<br>(95,796)<br>3,337,956<br>2,804,470<br>2,459,238<br>2,449,527<br>104,021<br>354,943<br>774,696<br>-<br>3,337,956<br>2,804,470|
|---|---|---|



The financial statements were approved and authorised for issue by the Board of Trustees on                             and were signed on its behalf by:- 


|Liz Lawrence-Blake|Karen Cross|
|---|---|
|Trustee|Trustee|



**The notes on pages 30 to 45 form part of these financial statements.** The notes on pages 29 to 44 form part of these financial statements. 

**28** 



## **CHILTERNS NEURO CENTRE LTD. CONSOLIDATED CASH FLOW STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2025** 

|31.12.2025<br>Notes<br>£<br>**Cash flows from operating activities:**<br>Cash generated from operations<br>1<br>599,122<br>Interest paid<br>(6,808)<br>**Net cash provided by / (used in) operating activities**<br>592,314<br>**Cash flows from investing activities:**<br>Purchase of tangible fixed assets<br>(17,816)<br>Restricted Endowment Fund Transferred to Fixed Assets<br>(774,696)<br>Unrestricted Fund Transferred to Fixed Assets<br>(10,156)<br>Gains / (Losses) on Investments<br>88,087<br>Interest received<br>18,042<br>**Net cash provided by / (used in) investing activities**<br>(696,539)<br>**Cash flows from financing activities:**<br>Loan repayments in year<br>(13,656)<br>**Net cash provided by / (used in) financing activities**<br>(13,656)<br>**Change in cash and cash equivalents in the reporting period**<br>(117,880)<br>**Cash and cash equivalents at the beginning of the reporting period**<br>497,254<br>**Cash and cash equivalents at the end of the reporting period**<br>379,374|31.12.2024<br>£<br>193,595<br>(8,592)<br>185,003<br>(58,532)<br>0<br>0<br>0<br>9,231<br>(49,301)<br>(12,355)<br>(12,355)<br>123,347<br>373,907<br>497,254|
|---|---|



> **The notes on pages 30 to 45 form part of these financial statements.** The notes on pages 40 to 54 form part of these financial statements. 

**29** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **1 RECONCILIATION OF NET INCOME/(EXPENDITURE) TO NET CASH FLOW FROM OPERATING ACTIVITIES** 

|Donated professional services and donated facilities are<br>**Adjustments for:**<br>Depreciation charges<br>Interest received<br>Interest paid<br>(Increase)/decrease in stocks<br>(Increase)/decrease in debtors<br>Increase/(decrease) in current creditors excluding bank loans and overdrafts<br>Net cash provided by / (used in) operating activities<br>**Net income/(expenditure) for the reporting period (as per the consolidated**<br>**statement of financial activities)**|31.12.2025<br>£<br>445,485<br>77,199<br>(18,042)<br>6,808<br>(4,087)<br>57,694<br>34,065<br>599,122|31.12.2024<br>£<br>143,811<br>91,130<br>(9,231)<br>8,593<br>2,292<br>(59,628)<br>16,628<br>193,595|
|---|---|---|



## **2 ANALYSIS OF CHANGES IN NET DEBT** 

|Cash<br>Loans falling due within one year<br>Loans falling due after more than one year|At<br>01.01.2025<br>£<br>497,254<br>(7,317)<br>(95,795)<br>394,142|Cash<br>Flows<br>£<br>(104,223)<br>(104,223)|Other<br>non cash<br>changes<br>£<br>(13,656)<br>(4,769)<br>18,425<br>0|At<br>31.12.2025<br>£<br>379,375<br>(12,086)<br>(77,370)<br>289,919|
|---|---|---|---|---|



**30** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **1 STATUTORY INFORMATION** 

Chilterns Neuro Centre Ltd. is a private company limited by guarantee incorporated in England and Wales.  The registered office is Oakwood Close, Wendover, Aylesbury, Buckinghamshire HP22 5LX. 

The presentation currency of the financial statements is the Pound Sterling (£) and the financial statements are rounded to the nearest £. 

## **2 ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ir **e** land (FRS 102) (issued in October 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', and the Companies Act 2006. 

Chilterns Neuro Centre Ltd. meets the definition of a public benefit entity under FRS102. The financial statements have been prepared under the historical cost convention with the exception of investments which are included at market value. 

At the date of approving these financial statements the trustees believe the charity has sufficient resources to ensure continued operational existence for the foreseeable future. The financial statements have therefore been prepared on the basis that the charity is a going concern. 

## **Preparation of consolidated financial statements** 

The consolidated financial statements incorporate those of the Chilterns Neuro Centre and its wholly owned subsidiary Oakwood Wellbeing Limited on a line by line basis. Details of the subsidiary results are given in note 15. As permitted by section 408 of the Companies Act 2006, the SOFA of the parent company is not presented as part of these financial statements. 

## **Income** 

Governance costs include those related to the cost of governance of the charity and its assets and are primarily associated with the compliance with constitutional and statutory requirements. 

Recognition of income from donations will be deferred if the donor has specified the donation must be spent in a future accounting period(s) or if certain conditions have been imposed which must be met before the charity has unconditional entitlement. The gift aid associated with a donation is recognised when the donation is received by the charity. Gifts in kind are included at valuation at the time of the gift. 

Subscription income is recognised in the year to which it relates and deferred in so much as it relates to a subsequent period. 

The charity receives grants from Clinical Commissioning Groups which are accrued in accordance with calculations based on monthly clinical activity data provided. 

For legacies, entitlement is taken as the earlier of the date on which either: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the estate that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor's intention to make a distribution. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material. 

**31** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2 ACCOUNTING POLICIES - continued** 

## **Donated services and facilities** 

Donated professional services and donated facilities are recognised as income when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS102), the general volunteer time of the charity's volunteers is not recognised. 

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain the services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt. 

## **Expenditure** 

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. 

## **Raising funds** 

Raising funds includes all expenditure incurred by the charity to raise funds for its charitable purposes and includes costs of all fundraising activities, events and non-charitable trading. 

## **Charitable activities** 

The costs of charitable activities are those directly incurred in support of the charity's objectives and include the costs of running the building owned and used by the charity. 

## **Governance costs** 

Governance costs include those related to the cost of governance of the charity and its assets and are primarily associated with the compliance with constitutional and statutory requirements. 

## **Allocation and apportionment of costs** 

Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with use of the resources. 

**32** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2 ACCOUNTING POLICIES - continued** 

## **Investment Policy** 

The vision of the Chilterns Neuro Centre is to use all assets, including money, to strive to create a community in which people affected by neurological conditions can live life to the full. The Charity has the powers, expressed in their governing documents, to invest any money in any investments, securities or properties. The assets are in the form of grants, legacies and donations which can be restricted or unrestricted. The investment objective being to contribute to the mission of the Charity through providing a financial return to fund its activities, taking into account environmental, social and governance factors, balanced with the need to protect and enhance the value of the Charity. The Charity currently aims to exist in the long term and so takes a long term view of its investments. The Charity recognises that different levels of risk are attached to different types of investment, and that those investments which have higher long term financial returns may also have higher levels of volatility. The Charity accepts the level of risk attached to equities and will invest in a moderate risk balanced portfolio. It will avoid speculative and non-transparent investments. As the Charity spends both income and capital it will mitigate some of the volatility risks by holding sufficient levels of cash in short to medium term deposits. 

The Charity will avoid investing in companies whose activities are inconsistent with its mission. The Charity recognises it can have more impact through working with its investment manager, and will avoid knowingly investing in companies which are associated with health risks, human rights violation or engage in activities that cause social harm, Specifically:  The charity will avoid investment in companies that derive more than 5% of their revenue from the production of, or 10% of their revenue from the sales of, armaments, tobacco, alcohol, gambling or pornography. The Charity will not hold any government bonds in countries with high military expenditure or which support the arms trade. The Charity will continue to develop its understanding of how its investments can contribute to the vision and will develop its approach and activities accordingly. 

The Charity will delegate the management of the investment portfolio to an external investment manager. The appointment of the investment manager will be fully reviewed at least every ten years, with a mid term review at least every five years. The investment manager will be given authority to allocate the investments in line with the agreed investment strategy, subject to the ethical considerations and any particular instructions. 

The Board has overall responsibility for the investments and agrees upon the investment strategy and the appointment of an external investment manager. The Income generation and Finance committee (IGF) has delegated authority to review and manage the investments. The investments will be reviewed as a standing agenda item at it's monthly meetings. Performance will be measured on total return, risk-adjusted return, and other appropriate benchmarks, strategy will be adjusted as necessary following these regular reviews. The Chief Executive, Finance Manager and Chair of the IGF committee have authority to add/withdraw funds and sign letters to companies, regulatory bodies and the media on behalf of the Charity in line with the strategic framework or in areas of work agreed by the IGF. 

**33** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2 ACCOUNTING POLICIES - continued** 

## **Tangible fixed assets** 

Tangible assets are stated at cost less accumulated depreciation. The cost of minor additions or those below £500 are not capitalised. Depreciation is provided at the following annual rates in order to write off the cost of each asset, less estimated residual value, over its estimated useful life. 

Freehold property - 2% straight line (50 years) Plant and machinery etc. - 10%/33.3% straight line (3 to 10 years) Main pool - 6.67% straight line (15 years) -13.3% straight line (7.5 years, or to the end of Pool refurbishment life of the main pool if shorter) - 4% straight line (25 years) 

## **Stocks** 

Stocks are valued at the lower of cost and net realisable value on a FIFO basis after making due allowance for obsolete and slow moving items. 

## **Taxation** 

The charity is exempt from corporation tax on its charitable activities. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity.  Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Designated funds are funds set aside by the trustees out of unrestricted general funds for specific future purposes or projects. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

## **Leasing commitments** 

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the period of the lease. 

## **Pension costs and other post-retirement benefits** 

The charitable company operates a defined contribution pension scheme.  Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate. 

## **Cash and cash equivalents** 

Cash and cash equivalents include cash in hand and deposits held on call with the charity's banks. 

**34** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2** 

## **ACCOUNTING POLICIES - continued** 

## **Financial instruments** 

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. The trustees are of the opinion that the charity does not currently have any Financial Instruments falling within the definition of Section 12 of FRS 102. 

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument. 

## Basic financial assets 

Basic financial assets, which include debtors and cash and cash equivalents, are initially measured at transaction price including costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised. 

## Basic financial liabilities 

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Financial liabilities classified as payable within one year are not amortised. 

## Derecognition of financial liabilities 

Financial liabilities are derecognised when the charity's contractual obligations expire or are discharged or cancelled. 

## **Critical accounting estimates and judgements** 

There have been no judgements made by the trustees in applying the accounting policies which have had a significant effect on the amounts recognised in the financial statements. 

There have been no assumptions concerning the future, and other key sources of estimation uncertainty at the year end that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year. 

## **3 DONATIONS AND LEGACIES** 

|Donations from members<br>Gift aid<br>Other donations and legacies<br>Fundraising and collections|Unrestricted<br>Funds<br>£<br>98,652<br>36,650<br>245,784<br>258,467<br>639,553|Restricted<br>Funds<br>£<br>0<br>0<br>1,000<br>293,203<br>294,203|Endowment<br>Funds<br>£<br>0<br>0<br>0<br>500,000<br>500,000|31.12.2025<br>Total<br>£<br>98,652<br>36,650<br>246,784<br>1,051,670<br>1,433,756|31.12.2024<br>Total<br>£<br>103,515<br>40,850<br>129,289<br>873,385<br>1,147,039|
|---|---|---|---|---|---|



Other donations and legacies include £11,590 (2024: £13,840) being the value of goods and services donated to the charity during the year. 

**35** 



## **CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **4 OTHER TRADING ACTIVITIES** 

|Sales<br>Membership subscriptions<br>Outside usage<br>**5**<br>**INVESTMENT INCOME**<br>Bank interest receivable<br>Dividends from Investments<br>Interest from Investments<br>**6**<br>**INCOME FROM CHARITABLE ACTIVITIES**<br>Contributions from Clinical Commissioning Groups<br>**7**<br>**RAISING FUNDS**<br>**Raising donations, legacies and outside usage**<br>Staff costs<br>Fundraising Events<br>Sundries<br>Travel & subsistence<br>Cost of goods sold|31.12.2025<br>£<br>87,326<br>22,626<br>124,992<br>234,944<br>Unrestricted<br>Endowment<br>Total<br>Funds<br>Funds<br>Funds<br>2025<br>2025<br>2025<br>£<br>£<br>£<br>3,277<br>3,277<br>621<br>10,375<br>10,996<br>543<br>3,226<br>3,769<br>4,441<br>13,601<br>18,042<br>31.12.2025<br>Provision of<br>treatments,<br>care and<br>support for<br>people with<br>MS,<br>Parkinson's<br>and stroke<br>£<br>66,996<br>31.12.2025<br>£<br>273,896<br>30,315<br>5,566<br>0<br>13,569<br>323,346|31.12.2024<br>£<br>71,020<br>20,955<br>105,862<br>197,837<br>Unrestricted<br>Funds<br>2,024<br>£<br>9,231<br>-<br>-<br>9,231<br>31.12.2024<br>Provision of<br>treatments,<br>care and<br>support for<br>people with<br>MS,<br>Parkinson's<br>and stroke<br>£<br>66,996<br>31.12.2024<br>£<br>260,509<br>15,594<br>3,721<br>0<br>12,529<br>292,353|
|---|---|---|



**36** 



## **CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **8 CHARITABLE ACTIVITIES COSTS** 

|Provision  of treatments, care and<br>support for people with MS,<br>Parkinson's and stroke<br>**SUPPORT COSTS**<br>Management<br>Information<br>technology<br>£<br>£<br>Provision of treatments, care and<br>support for people with MS,<br>Parkinson's and stroke<br>197,237<br>13,908<br>Support costs, included in the above, are as follows:<br>Support Salaries<br>Social security<br>Pensions<br>Postage, printing and stationery<br>Travel<br>Sundries<br>IT costs<br>HR costs<br>Redundancy costs<br>Auditors' remuneration<br>**NET INCOME/(EXPENDITURE)**<br>Net income/(expenditure) is stated after charging/(crediting):<br>Auditors' remuneration<br>Depreciation - owned assets<br>Hire of plant and machinery|Direct<br>costs<br>£<br>749,963<br>Human<br>resources<br>£<br>8,479|Support costs<br>(See note 9)<br>£<br>234,944<br>Governance<br>costs<br>£<br>15,320<br>31.12.2025<br>Provision of<br>treatments,<br>care and<br>support for<br>people with<br>MS,<br>Parkinson's<br>and stroke<br>£<br>163,685<br>7,162<br>4,657<br>18,751<br>0<br>2,982<br>13,908<br>2,225<br>6,254<br>15,320<br>234,944<br>31.12.2025<br>£<br>15,320<br>77,199<br>0|Totals<br>£<br>984,907<br>Totals<br>£<br>234,944<br>31.12.2024<br>Provision of<br>treatments,<br>care and<br>support for<br>people with<br>MS,<br>Parkinson's<br>and stroke<br>£<br>157,114<br>10,434<br>4,488<br>7,752<br>11<br>5,708<br>23,113<br>2,092<br>0<br>8,808<br>219,520<br>31.12.2024<br>£<br>8,808<br>91,130<br>5,004|
|---|---|---|---|



## **9 SUPPORT COSTS** 

**10 NET INCOME/(EXPENDITURE)** 

**37** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **11 TRUSTEES' REMUNERATION AND BENEFITS** 

There were no trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year ended 31 December 2024. 

## **Trustees' expenses** 

There were no trustees' expenses paid for the year ended 31 December 2025 nor for the year ended 31 December 2024. 

## **12 STAFF COSTS** 

|Wages and salaries<br>Social security costs<br>Other pension costs<br>Therapy staff<br>Fundraising staff<br>Facilities staff<br>Administrative staff|31.12.2025<br>£<br>809,675<br>76,804<br>22,160<br>908,639<br>31.12.2025<br>16<br>7<br>2<br>4<br>29|31.12.2024<br>£<br>817,686<br>64,585<br>20,953<br>903,224<br>31.12.2024<br>18<br>7<br>2<br>4<br>31|
|---|---|---|



The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was: 

|£60,001 - £70,000|31.12.2025<br>1|31.12.2024<br>2|
|---|---|---|



The total employee benefits of the key management personnel of the Group and Charity were £282,615 (2024 £274,040). Key management personnel comprise the Chief Executive Officer together with the Senior Leadership Team. 

## **13 2024 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** 

|**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>**Charitable activities**<br>Contributions from Clinical Commissioning Groups<br>Other trading activities<br>Investment income<br>**Total**|Unrestricted<br>£<br>559,729<br>66,996<br>197,837<br>9,231<br>833,793|Restricted<br>£<br>587,310<br>0<br>0<br>0<br>587,310|Total  funds<br>£<br>1,147,039<br>66,996<br>197,837<br>9,231<br>1,421,103|
|---|---|---|---|



**38** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **13 2024 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued** 

|**EXPENDITURE ON**<br>Raising funds<br>**Charitable activities**<br>Provision of treatments, care and support for people with<br>MS, Parkinson's and stroke<br>**Total**<br>**NET INCOME/(EXPENDITURE)**<br>**Transfers between funds**<br>**RECONCILIATION OF FUNDS**<br>**Total funds brought forward**<br>**TOTAL FUNDS CARRIED FORWARD**<br>**14**<br>**TANGIBLE FIXED ASSETS - CHARITY (ALSO COMPRISING**<br>**COST**<br>At 1 January 2025<br>Additions<br>Disposals<br>At 31 December 2025<br>**DEPRECIATION**<br>At 1 January 2025<br>Charge for year<br>Disposals<br>At 31 December 2025<br>**NET BOOK VALUE**<br>At 31 December 2025<br>At 31 December 2024|Unrestricted<br>funds<br>Restricted<br>funds<br>£<br>£<br>292,353<br>0<br>667,509<br>317,430<br>959,862<br>317,430<br>(126,068)<br>269,879<br>44,940<br>(44,940)<br>(81,128)<br>224,939<br>2,531,324<br>130,002<br>2,450,196<br>354,941<br>**THAT OF THE GROUP)**<br>Freehold<br>property<br>Fixtures and<br>fittings<br>£<br>£<br>2,468,960<br>758,906<br>0<br>17,816<br>0<br>0<br>2,468,960<br>776,722<br>303,402<br>551,787<br>21,257<br>55,942<br>0<br>0<br>324,659<br>607,729<br>2,144,301<br>168,993<br>2,165,558<br>207,119|Total  funds<br>£<br>292,353<br>984,939<br>1,277,292<br>143,811<br>0<br>143,811<br>2,661,326<br>2,805,137<br>Totals<br>£<br>3,227,866<br>17,816<br>0<br>3,245,682<br>855,189<br>77,199<br>0<br>932,388<br>2,313,294<br>2,372,676|
|---|---|---|



**39** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**FIXED ASSET INVESTMENTS**<br>**MARKET VALUE**<br>Unlisted investment in subsidiary companies.<br>Quilter Cheviot Investment Fund 1 - Endowment Fund<br>Quilter Cheviot Investment Fund 2 - Unrestricted Fund<br>At 1 January 2025<br>Additions<br>Disposals<br>Revaluations<br>Cash movements<br>At 31 December 2025|Group<br>31.12.2025<br>31.12.2024<br>£<br>£<br>0<br>0<br>774,696<br>0<br>10,156<br>0<br>784,852<br>0<br>**Listed**<br>**Investments**<br>**Cash on**<br>**Investment**<br>**Portfolio**<br>-<br>-<br>678,721<br>-<br>77,275<br>-<br>-<br>88,087<br>-<br>-<br>95,319<br>689,533<br>95,319|Charity<br>31.12.2025<br>31.12.2024<br>£<br>£<br>100<br>100<br>774,696<br>0<br>10,156<br>0<br>784,952<br>100<br>**Total**<br>-<br>678,721<br>77,275<br>-<br>88,087<br>95,319<br>784,852|
|---|---|---|



## **15 FIXED ASSET INVESTMENTS** 

## Unlisted investment in subsidiary companies. 

The charity holds 100 shares of £1 each in its wholly owned trading subsidiary company Oakwood Wellbeing Limited which was incorporated in the United Kingdom  on 7 September 2016 (registration number 10363280). Profits from the subsidiary are paid to the charity under the gift aid payment scheme. A summary of the financial performance of the subsidiary for the period 1 January  to 31 December 2025 (1 January to 31 December 2024) is:- 

|Income<br>Less direct operating expenditure<br>Less service charge from parent charity<br>Net profit<br>Total equity brought forward<br>Profit for the financial year<br>Amount gift aided to the charity - prior year profits<br>Amount gift aided to the charity - current year profits<br>Total equity carried forward|31.12.2025<br>£<br>124,991<br>(18,509)<br>(32,400)<br>74,082<br>670<br>74,082<br>0<br>(74,000)<br>752|31.12.2024<br>£<br>105,862<br>(16,321)<br>(32,892)<br>56,649<br>321<br>56,649<br>0<br>(56,300)<br>670|
|---|---|---|



The net contribution Oakwood Wellbeing Limited made to the parent charity in the year was £106,400 (2024: £89,192) being the total of the service charge and gift aided profit. 

|**16**<br>**STOCKS**<br>Stocks<br>**17**<br>**DEBTORS**<br>Trade debtors<br>Prepayments and accrued income<br>Amounts owed by group undertakings|Group<br>31.12.2025<br>31.12.2024<br>£<br>£<br>6,231<br>2,144<br>Group<br>31.12.2025<br>31.12.2024<br>£<br>£<br>15,003<br>14,863<br>22,494<br>88,128<br>7,800<br>0<br>45,297<br>102,991|Charity<br>31.12.2025<br>31.12.2024<br>£<br>£<br>6,231<br>2,144<br>Charity<br>31.12.2025<br>31.12.2024<br>£<br>£<br>5,583<br>6,250<br>22,494<br>88,128<br>34,970<br>32,027<br>63,047<br>126,405|
|---|---|---|



## **Funds received as agents** 

During the year the charity received £34,330 (2024: £26,006) as an agent for exhibitors at its annual art exhibition. The exhibitors donated £15,540 (2024: £10,004) in total to the charity and the charity therefore paid the balance of £18,790 (2024: £16,002) to the exhibitors. 

**40** 



**CHILTERNSNEUROS CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **18 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

||Group|Group|Charity|Charity|
|---|---|---|---|---|
||31.12.2025|31.12.2024|31.12.2025|31.12.2024|
||£|£|£|£|
|Bank loans and overdrafts (see note 20)|12,090|7,317|12,090|7,317|
|Trade creditors|37,642|14,335|29,842|14,254|
|Social security and other taxes|22,221|26,451|22,221|26,451|
|Accruals and deferred income|41,015|26,028|41,017|7,239|
||112,968|74,131|105,170|55,261|
|Deferred income amounting to £33,017 (2024: £3,469) at the balance sheet date comprises grants received with|||||
|time related restrictions and membership income received in advance.|||||
|**CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR**|||||
|Bank loans (see note 20)|Group<br>31.12.2025<br>31.12.2024<br>£<br>£<br>77,370<br>95,796||Charity<br>31.12.2025<br>31.12.2024<br>£<br>£<br>77,370<br>95,796||
|**LOANS**|||||
|An analysis of the maturity of loans is given below:|Group||Charity||
|Amounts falling due within one year on demand:|31.12.2025<br>£|31.12.2024<br>£|31.12.2025<br>£|31.12.2024<br>£|
|Bank loans|12,090|7,317|12,090|7,317|
|Amounts falling due between two and five years:|||||
|Bank loans - 2-5 years|57,018|38,024|57,018|38,024|
|Amounts falling due in more than five years:|||||
|Bank loans more than 5 years by instalments|20,352|57,772|20,352|57,772|



## **19 CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR** 

## **20 LOANS** 

## **21 OPERATING LEASE COMMITMENTS - CHARITY (ALSO COMPRISING THAT OF THE GROUP)** 

Minimum lease payments fall due as follows: 

|Other operating leases<br>Expiring:<br>between two and five years|31.12.2025<br>£<br>29,875<br>77,585<br>107,460|31.12.2024<br>£<br>106,849<br>106,849|
|---|---|---|



**41** 



**CHILTERNS NEURO CENTRE LTD.** 

**NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **22 SECURED DEBTS  - CHARITY (ALSO COMPRISING THAT OF THE GROUP)** 

The following secured debts are included within creditors: 

|31.12.2025<br>£<br>89,460|31.12.2024<br>£<br>103,113|
|---|---|



The bank loan is secured by two legal charges, the first being over the freehold property of the charity and all associated assets. The charity entered into a bank loan agreement for £475,000 in 2012 so as to finance its new building.  This loan was restructured in 2012 at a value of £216,736 and  is repayable over a period of 15 years commencing January 2015 at an interest rate of 2.75% above base rate. The trustees believe that the charity will receive sufficient donations to be able to repay this loan in line with its terms. The second legal charge is fixed and floating over the charity and all its assets present and future. 

## **23 MOVEMENT IN FUNDS** 

|**Unrestricted funds**<br>At 01.01.2025<br>Income<br>£<br>£<br>Group - General fund<br>2,450,196<br>945,934<br>Charity - General fund<br>2,449,528<br>927,338<br>**Restricted funds - Charity (also comprising that of the Group)**<br>At 01.01.2025<br>Income<br>£<br>£<br>Reception & Garden Furniture<br>1,567<br>0<br>Physiotherapy  Equipment<br>344<br>0<br>Occupational Therapy Fund<br>947<br>0<br>Allergan Fund<br>5,192<br>0<br>Aims2Cure Pilates Fund<br>10,448<br>0<br>Rothschild Wellbeing Fund<br>13,907<br>0<br>Leisure Group Fund<br>134<br>0<br>Physio salaries<br>3,000<br>107,500<br>Oxygen<br>1,720<br>4,750<br>National Lottery<br>75,000<br>150,000<br>Ernest Hecht Fund IT<br>12,684<br>0<br>The Edward Gostling Fund<br>230,000<br>0<br>Fairhive Homes Ltd<br>0<br>8,700<br>Mulberry Trust<br>0<br>10,000<br>Stockwell Cliffe<br>0<br>3,000<br>The Access Foundation<br>0<br>5,000<br>Mobbs Memorial Trust<br>0<br>3,253<br>Hospital Saturday Fund<br>0<br>2,000<br>354,943<br>294,203<br>**Endowment Funds**<br>The Edward Gostling Fund<br>0<br>4,285<br>Ernest Hecht Foundation<br>0<br>509,316<br>0<br>513,601<br>Total Restricted Funds<br>354,943<br>807,804<br>**GROUP - TOTAL FUNDS**<br>2,805,139<br>1,753,738<br>**CHARITY - TOTAL FUNDS**<br>2,804,471<br>1,735,142|Expenditure<br>£<br>(1,005,812)<br>(987,303)<br>Expenditure<br>£<br>(1,134)<br>(344)<br>(947)<br>(2,052)<br>(5,348)<br>(13,907)<br>(7)<br>(110,500)<br>(6,470)<br>(143,058)<br>0<br>0<br>(8,700)<br>(9,974)<br>0<br>0<br>0<br>0<br>(302,441)<br>0|Gains /<br>(Losses)<br>£<br>3,992<br>3,992<br>Gains /<br>(Losses)<br>£<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>26,496|Transfers<br>£<br>65,684<br>65,684<br>Transfers<br>£<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>(12,684)<br>(230,000)<br>0<br>0<br>0<br>0<br>0<br>0<br>(242,684)<br>177,000<br>0<br>177,000<br>(65,684)<br>0<br>0|At 31.12.2025<br>£<br>2,459,994<br>2,459,239<br>At 31.12.2025<br>£<br>433<br>0<br>0<br>3,140<br>5,100<br>0<br>127<br>0<br>0<br>81,942<br>0<br>0<br>0<br>26<br>3,000<br>5,000<br>3,253<br>2,000<br>104,021<br>207,781<br>566,915<br>774,696<br>878,717<br>3,338,711<br>3,337,956|
|---|---|---|---|---|
||0|57,599|||
||0<br>(302,441)<br>(1,308,253)<br>(1,289,744)|84,095<br>84,095<br>88,087<br>88,087|||



The transfer between funds reflects expenditure on capital items in accordance with the terms of the fund, and to more accurately show The Edward Gostling Fund as Endowment. 

**42** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **23 MOVEMENT IN FUNDS - COMPARATIVES** 

|**Unrestricted funds**<br>Group - General fund<br>Charity - General fund<br>**Restricted funds**<br>Reception & Garden Furniture<br>Physiotherapy  Equipment<br>Owens building infrastructure Fund<br>Occupational Therapy Fund<br>Hardship Fund<br>Allergan Fund<br>Aims2Cure Pilates Fund<br>Rothschild Wellbeing fund<br>Leisure Group Fund<br>Physiotherapy Salaries<br>Oxygen<br>National Lottery<br>St James Trust<br>The Edward Gostling Fund<br>Ernest Hecht Fund<br>**GROUP - TOTAL FUNDS**<br>**CHARITY - TOTAL FUNDS**|At 01.01.2024<br>£<br>2,531,324<br>2,531,000<br>1,567<br>17,344<br>3,815<br>0<br>150<br>5,192<br>2,844<br>0<br>134<br>12,439<br>1,517<br>75,000<br>10,000<br>0<br>0<br>130,002<br>2,661,326<br>2,661,002|Income<br>£<br>833,793<br>816,331<br>0<br>14,125<br>0<br>3,000<br>0<br>0<br>14,400<br>45,000<br>0<br>112,601<br>5,500<br>150,000<br>0<br>230,000<br>12,684<br>587,310<br>1,421,103<br>1,403,641|Expenditure<br>£<br>(959,861)<br>(942,748)<br>0<br>0<br>0<br>(2,054)<br>(150)<br>0<br>(6,796)<br>(31,093)<br>0<br>(122,041)<br>(5,297)<br>(150,000)<br>0<br>0<br>0<br>(317,431)<br>(1,277,292)<br>(1,260,178)|Transfers At 31.12.2024<br>£<br>£<br>44,940<br>2,450,196<br>44,940<br>2,449,523<br>0<br>1,567<br>(31,125)<br>346<br>(3,815)<br>0<br>0<br>946<br>0<br>0<br>0<br>5,192<br>0<br>10,448<br>0<br>13,907<br>0<br>134<br>0<br>2,999<br>0<br>1,720<br>0<br>75,000<br>(10,000)<br>0<br>0<br>230,000<br>0<br>12,684<br>(44,940)<br>354,943<br>#<br>0<br>2,805,139<br>0<br>2,804,471|
|---|---|---|---|---|



The Reception & Garden Furniture Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the refit of the Centre reception area. 

The Physiotherapy Equipment Fund relates to donations received by the charity where they wish for the funds to be applied towards the purchase of physiotherapy equipment. 

The Occupational Therapy Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on Occupational therapy services. 

The Hardship Fund relates to a donation received by the charity where the donor has agreed to support members unable to pay membership fees through financial hardship. 

The Allergan Fund relates to a donation received by the charity where the donor has stated they wish for the donation to be spent on fundraising costs. 

**43** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **23 MOVEMENT IN FUNDS (CONTINUED)** 

The Rothschild Wellbeing Fund relates to donations received by the charity where the donor has stated they wish the donations to be spent on the provision of wellbeing activities. 

The Leisure Group Fund relates to donations received by the charity where the donor has stated they wish the donations to be spent on therapeutic leisure group activities. 

The Physiotherapy Salaries Fund relates to donations received by the charity where the donors stated that the funds should be used to fund the provision of physiotherapy. 

The Oxygen Supplies Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the operational costs of the oxygen chamber. 

The Edward Gostling Fund is an endowment fund that has been granted to meet operating costs of charitable activities should free reserves fall below 3 months of operational expenditure. 

Fairhive Homes Ltd relates to donations received where this donor has stated the funds should be used in the provision of wellbeing activities. 

Mulberry Trust relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the provision of counselling services 

Stockwell Cliffe relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the provision of wellbeing services 

The Access Foundation relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the provision of Physiotherapy services 

Mobbs Memorial Trust relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the provision of physiotherapy equipment. 

Hospital Saturday Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the provision of physiotherapy services 

## **Endowment Funds** 

## The Ernest Hecht Charitable Foundation Fund — £500,000 

This gift, made under a Deed of Gift dated 28 February 2025, exists to safeguard the continuity of our physiotherapy programme. Under the terms of the Deed, for a period of at least eight years from 1 January 2026 the Centre must allocate **£65,000 each year, restricted solely to the provision of physiotherapy** . The balance must remain prudently invested, with all investment returns ring-fenced for the physiotherapy programme. 

## — The Edward Gostling Fund £230,000 

This endowment, established by a Deed of Gift dated 12 March 2024, is held and reported in our accounts as “The Edward Gostling Fund”. For five years from that date, the fund may only be used to meet operating costs, and then only as a safety net: drawdowns in any accounting year are limited to the amount needed to prevent our reserves falling below three months’ operating costs, in line with the Charity Commission’s reserves guidance (CC19). In effect, the fund **protects the Centre’s resilience rather than funding routine expenditure** . From 12 March 2029 any income and remaining capital may be applied to any purpose within our charitable objects. 

**44** 



**CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **24a ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS** 

|£<br>Tangible fixed assets<br>2,313,294<br>Investments<br>10,156<br>Current Assets<br>326,882<br>Creditors falling due within one year<br>(112,968)<br>Creditors falling due after more than one year<br>(77,370)<br>2,459,994<br>**24b**<br>£<br>Tangible fixed assets<br>2,372,677<br>Current Assets<br>247,446<br>Creditors falling due within one year<br>(74,132)<br>Creditors falling due after more than one year<br>(95,796)<br>2,450,195<br>**ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS**<br>**(PRIOR YEAR)**<br>Unrestricted funds<br>Unrestricted funds|Restricted<br>funds<br>£<br>0<br>104,021<br>0<br>0<br>104,021<br>Restricted<br>funds<br>£<br>0<br>354,943<br>0<br>0<br>354,943|Endowment<br>funds<br>£<br>774,696<br>0<br>0<br>0<br>774,696<br>Endowment<br>funds<br>£<br>0<br>0<br>0<br>0<br>0|31<br>December<br>2025 Total<br>£<br>2,313,294<br>784,852<br>430,903<br>(112,968)<br>(77,370)<br>3,338,711<br>31<br>December<br>2024 Total<br>£<br>2,372,677<br>602,390<br>(74,132)<br>(95,796)<br>2,805,139|
|---|---|---|---|



## **24 PENSION COMMITMENTS** 

During the year the charity contributed a total of £22,160 (2024: £21,316) to defined contribution schemes.  This cost has been charged as an expense and analysed across activities in accordance with the allocation of the related employee salaries. At 31 December 2025, based on the employee salaries at the time, there was an annualised commitment of £24,254 (2024: £22,830). 

## **25 RELATED PARTY DISCLOSURES** 

The charitable company has one subsidiary, Oakwood Wellbeing Limited as detailed in note 15 above. During the year, this subsidiary made payments under the gift aid payment scheme to the charitable company of £74,000 (2024: £56,300).  During the year £13,802 (2024: £13,379) of expenditure was recharged to Oakwood Wellbeing Limited as well as a service charge of £32,400 (2024: £32,100) paid to Chilterns Neuro Centre. At the year end £27,170 (2024: £32,027) was owed to Chilterns Neuro Centre from Oakwood Wellbeing Limited. 

## **26 ULTIMATE CONTROLLING PARTY** 

Chilterns Neuro Centre Ltd. is an incorporated charity under the control of the trustees collectively. 

## **27 COMPANY LIMITED BY GUARANTEE** 

The liability of each member is limited to £10 by guarantee. 

**45** 




Chilterns Neuro Centre Ltd. 

Oakwood Close, Wendover, Buckinghamshire HP22 5LX 01296 696133 | info@chilternsneurocentre.org chilternsneurocentre.org Registered charity no: 800853 | Registered company no: 02294557 

